首页 | 本学科首页   官方微博 | 高级检索  
     

康忻与合心爽联合治疗不稳定型心绞痛临床研究
引用本文:郭茂彧,宁观林. 康忻与合心爽联合治疗不稳定型心绞痛临床研究[J]. 齐齐哈尔医学院学报, 2012, 33(8): 1021-1022
作者姓名:郭茂彧  宁观林
作者单位:郭茂彧 (广东省吴川市人民医院,525400) ; 宁观林 (广东省吴川市人民医院,525400) ;
摘    要:目的探讨康忻与合心爽治疗不稳定型心绞痛(UPA)的疗效和安全性。方法将UPA患者随机分为治疗组73例,对照组72例。治疗组用康忻1.25~5mg,1次/d,合心爽30~60mg,1次/8h,共14d;对照组用安慰剂口服,1次/d,合心爽30~60mg,1次/8h,共14d。结果治疗组疗效明显优于对照组,治疗组总有效率95.4%,对照组总有效率85.7%,两组在疗效上差异有统计学意义(P<0.05)。结论治疗组比对照组效果好、安全性可靠。

关 键 词:康忻  合心爽  不稳定型心绞痛  疗效

Clinical research on Bisoprolol Fumarate Tablets in combination with Diltiazem Hydrochloride Tablets in UPA treatment
Affiliation:GUO Mao-yu,et al.(People’s Hospital,Wuchuan,Guangdong,524500,the P.R.China.)
Abstract:Objective To investigate the efficacy and safety of using Bisoprolol Fumarate Tablets in combination with Diltiazem Hydrochloride Tablets to treat UPA.Methods The UPA patients were divided into two groups stochastically: the treatment group(n=73) and the control group(n=72).The patients in the treatment group took 1.25~5mg Bisoprolol Fumarate Tablets once a day and 30~60mg and Diltiazem Hydrochloride Tablets once eight hours for two weeks.The patients in the control group took Placebot once a day and 30~60mg Diltiazem Hydrochloride Tablets once eight hours for two weeks.Results Therapeutic outcome of the treatment group was obviously better than that of the control group with the cure rate 95.4% v 85.7%,which was really meaningful(P<0.05).Conclusions The treatment in the first group has got a better effect and is more reliably safe.
Keywords:Bisoprolol Fumarate Tablets Diltiazem Hydrochloride Tablets UPA Therapeutic outcome
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号